Culture-negative sepsis ... rendering many standard treatments ineffective,” it read. Klebsiella pneumoniae (22.9%), Escherichia coli (14.8%), coagulase-negative staphylococci (13.9%) and ...

FDA approves new UTI antibiotic that may help patients with recurring infections - A commercial launch of the antibiotic in ...

For the longest the only treatment available for an uncomplicated UTI was nitrofurantoin. But now, FDA has approved Blujepa, ...

"Unprotected city" - this is what infants are during the first six months of life, and the resurgence of whooping cough - also known as the 100-day cough - poses a serious threat to their health ...

phenotype in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae (CRKp) pathogenicity warrants investigation for public health risk assessment. Results: The Wzc mutations are identified as the key to ...

The occurrence of culture-proven bacterial infections in the bloodstream ... prevalence of multidrug-resistant gram-negative bacterial infections, such as Klebsiella pneumonia and Escherichia coli, at ...

Maternal labs reported that she was blood type AB positive, antibody screen negative, rubella immune, and recent GBS vaginal/rectal culture negative ... and recurrent pneumonia with hospitalizations ...

Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.

This includes Carbapenems used to treat multi-drug resistant Klebsiella pneumoniae usually found in urine and Pseudomonas aeruginosa that commonly exists in the environment, in water, plants and ...